Inflammatory cells and bone loss in rheumatoid arthritis

被引:19
作者
Haynes, David R. [1 ]
机构
[1] Univ Adelaide, Sch Med Sci, Discipline Pathol, Adelaide, SA 5005, Australia
关键词
D O I
10.1186/ar2213
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Pathogenic bone erosion is often associated with inflammation. The destructive bone erosion that is often seen in rheumatoid arthritis is probably due to the close proximity of inflamed tissues to bone. Over the past decade, major advances have been made in our understanding of the factors that are crucial in regulating osteoclast bone resorption. It is not surprising that these factors are expressed by inflammatory cells that are present in the rheumatoid joint. It now appears that we can add neutrophils to the list of inflammatory cells found in the inflamed rheumatoid joint that express factors that regulate bone erosion.
引用
收藏
页数:3
相关论文
共 19 条
[1]
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1 [J].
Bendixen, AC ;
Shevde, NK ;
Dienger, KM ;
Willson, TM ;
Funk, CD ;
Pike, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2443-2448
[2]
Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis [J].
Collin-Osdoby, P ;
Rothe, L ;
Anderson, F ;
Nelson, M ;
Maloney, W ;
Osdoby, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20659-20672
[3]
Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients:: semiquantitative and quantitative analysis [J].
Crotti, TN ;
Smith, MD ;
Weedon, H ;
Ahern, MJ ;
Findlay, DM ;
Kraan, M ;
Tak, PP ;
Haynes, DR .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (12) :1047-1054
[4]
Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO
[5]
2-P
[6]
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies normal controls [J].
Haynes, DR ;
Barg, E ;
Crotti, TN ;
Holding, C ;
Weedon, H ;
Atkins, GJ ;
Zannetino, A ;
Ahern, MJ ;
Coleman, M ;
Roberts-Thomson, PJ ;
Kraan, M ;
Tak, PP ;
Smith, MD .
RHEUMATOLOGY, 2003, 42 (01) :123-134
[7]
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint [J].
Haynes, DR ;
Crotti, TN ;
Loric, M ;
Bain, GI ;
Atkins, GJ ;
Findlay, DM .
RHEUMATOLOGY, 2001, 40 (06) :623-630
[8]
Activated T lymphocytes support osteoclast formation in vitro [J].
Horwood, NJ ;
Kartsogiannis, V ;
Quinn, JMW ;
Romas, E ;
Martin, TJ ;
Gillespie, MT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :144-150
[9]
Komuro H, 2001, ARTHRITIS RHEUM, V44, P2768, DOI 10.1002/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO
[10]
2-I